tiprankstipranks
XORTX Therapeutics Inc (TSE:XRTX)
TSXV:XRTX

XORTX Therapeutics Inc (XRTX) Financial Statements

24 Followers

XORTX Therapeutics Inc Financial Overview

XORTX Therapeutics Inc's market cap is currently ―. The company's EPS TTM is C$-1.868; its P/E ratio is -1.43; XORTX Therapeutics Inc is scheduled to report earnings on August 23, 2024, and the estimated EPS forecast is C$-0.68. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -3.02MC$ 2.70MC$ -1.33MC$ -1.69MC$ -1.83M
EBITDAC$ -2.99MC$ 2.72MC$ -1.32MC$ -1.66MC$ -1.77M
Net Income Common StockholdersC$ -3.02MC$ 2.70MC$ -1.33MC$ -1.69MC$ -1.83M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 3.84MC$ 3.45MC$ 5.07MC$ 6.16MC$ 7.91M
Total AssetsC$ 6.05MC$ 5.47MC$ 6.64MC$ 7.80MC$ 9.66M
Total DebtC$ 14.04KC$ 11.51KC$ 28.51KC$ 45.19KC$ 61.54K
Net DebtC$ -3.82MC$ -3.44MC$ -5.04MC$ -6.12MC$ -7.85M
Total LiabilitiesC$ 3.56MC$ 825.94KC$ 553.76KC$ 403.26KC$ 599.79K
Stockholders EquityC$ 2.49MC$ 4.64MC$ 6.09MC$ 7.40MC$ 9.06M
Cash Flow-
Free Cash FlowC$ -1.31MC$ -1.31MC$ -1.08MC$ -1.74MC$ -2.50M
Operating Cash FlowC$ -1.30MC$ -1.30MC$ -1.07MC$ -1.73MC$ -2.48M
Investing Cash FlowC$ -2.62KC$ -9.79KC$ -7.30KC$ -9.54KC$ -19.73K
Financing Cash FlowC$ 1.70MC$ -312.25KC$ -16.67KC$ -8.76KC$ -23.36K
Currency in CAD

XORTX Therapeutics Inc Earnings and Revenue History

XORTX Therapeutics Inc Debt to Assets

XORTX Therapeutics Inc Cash Flow

XORTX Therapeutics Inc Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis